从病例规模到学习型体系:甲状腺肿瘤学科建设的路径与展望OA
From case volume to learning systems:pathways and prospects for thyroid oncology discipline development
近年来,中国甲状腺癌发病率持续上升,已成为我国发病率增长最快的实体瘤之一.与欧美国家相比,中国甲状腺癌呈现低危乳头状甲状腺癌病人数量庞大与晚期高危病人诊疗需求并存的"双重疾病负担"特征.如何实现低危病人分层诊疗与高危病人强化综合治疗,已成为我国甲状腺肿瘤学科发展的核心命题.本文结合国内外最新研究进展及复旦大学附属肿瘤医院近年来相关探索,系统总结我国甲状腺肿瘤学科建设的发展路径.文章认为,高质量标准化临床数据库与生物样本库是学科建设的基础设施;人工智能(AI)有望推动数据治理、动态风险分层及全程管理;新辅助治疗是局部晚期或高危甲状腺癌精准诊疗体系的重要组成部分;多学科协作与全国协同网络是推动少见及高危甲状腺癌研究的重要组织形式.未来应借鉴肺癌、乳腺癌等实体瘤成熟科研体系经验,构建以数据驱动、多学科协作和持续迭代的学习型精准诊疗体系,为甲状腺癌优化诊疗提供循证中国方案.
In recent years,the incidence of thyroid cancer in China has risen steadily,rendering it one of the most rapidly increasing solid malignancies nationwide.Relative to Western populations,China confronts a"dual disease burden":a substantial cohort of patients with low-risk papillary thyroid carcinoma coexists alongside pressing clinical needs for effective management of advanced and high-risk disease.Consequently,implementing risk-stratified management for low-risk patients—while delivering intensified,multimodal therapeutic strategies for high-risk cases—has emerged as a pivotal challenge in advancing thyroid oncology in China.This article presented a systematic review of the evolution of thyroid tumor disciplines in China,synthesizing cutting-edge domestic and international research evidence alongside recent institutional innovations at Fudan University Shanghai Cancer Center.It underscored four critical enablers of discipline advancement:(1)high-quality,standardized clinical databases and biobanks as foundational infrastructure;(2)artificial intelligence(AI)-driven enhancements in data curation,dynamic risk stratification,and longitudinal care coordination;(3)neoadjuvant therapy as an integral pillar of precision medicine for locally advanced or high-risk thyroid cancer;and(4)robust multidisciplinary collaboration and scalable national research networks as essential organizational frameworks for investigating rare and aggressive subtypes.Looking ahead,China is well positioned to adapt proven translational research paradigms from lung and breast cancer—particularly those grounded in learning health systems—to establish a data-informed,multidisciplinary collaboration,and iteratively refined learning health system of precision medicine,thereby contributing a distinctive,evidence-based Chinese model for optimized diagnosis and treatment for thyroid cancer.
王宇
复旦大学附属肿瘤医院头颈外科,复旦大学上海医学院肿瘤学系,上海 200032
医药卫生
甲状腺癌精准诊疗数据库人工智能多学科协作学习型医疗体系
Thyroid cancerPrecision medicineDatabaseArtificial intelligence(AI)Multidisciplinary collaborationLearning health system
《外科理论与实践》 2026 (4)
279-286,8
国家科技重大专项(四大慢病重大专项)(2024ZD0525600)国家自然科学基金(82473361)上海市科学技术委员会上海市2025年度科技产业高质量发展计划(25SF1900700)上海申康医院发展中心上海临床队列项目(SHDC2025CCS028)上海申康医院发展中心促进市级医院临床技能与临床创新三年行动计划(SHDC2020CR6003)上海申康医院发展中心诊疗技术推广及优化管理项目(SHDC22025203)上海市抗癌协会翱翔计划(SACA-AX202404)上海市徐汇区卫生健康委员会、徐汇区科学技术委员会院地合作项目(生命健康领域)(25XHYD-11)
评论